Acadia Pharmaceuticals announces retirement of R&D head, names interim consultant
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Merck and Moderna release promising data on cancer vaccine trial
A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence.
Pharmacies emerge as new K-beauty stops for foreign tourists
In Seoul's bustling Namdaemun Market, a group of American tourists stepped out of a pharmacy and opened their shopping bags to show their haul: a box of Bacchus energy drinks and three packages of…
Ebola vaccine trial begins in DR Congo
WHO chief Tedros Adhanom Ghebreyesus said on X: 'Science gives us hope. Today, in Bunia DRC, the first participants were vaccinated in a new Ebola vaccine trial called Tumaini, which means 'hope' in…
Cancer couldn’t stop this M’sian dancer from chasing her dreams
Despite life-threatening health setbacks at just 19, London-based Rhen Teh refused to let adversity keep her from returning to the art she loves.
Reprogramming tumor microenvironment could improve prospects for treatment of pancreatic cancer
Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is the dense tissue surrounding the tumor that acts as a protective barrier and suppresses the immune response. It is a complex tissue made of supporting cells, blood vessels and immune cells—the tumor microenvironment.
Kenya: 'Burden and Loss' Builds in DR Congo, As Kenya Strengthens Ebola Containment
[UN News] As Ebola continues to spread in the Democratic Republic of the Congo (DRC), more resources are needed to fight the disease and feed patients and families, UN agencies said on Friday.